|
I-Catalyst Program - IIU Design Sprint |
GenIC Submission under OMB #0920-1158 |
Juliana K. Cyril, MPH, PhD Director, Office of Technology and Innovation Office of the Associate Director for Science Centers for Disease Control and Prevention Ph: 404-639-4639 Fax: 404-639-4903
Team Lead – Mary Peck, CSELS
Submission Date: 5-8-2017 OMB Project Number: 0920-1158
|
1. Circumstances Making the Collection of Information Necessary 3
2. Purpose and Use of Information Collection 3
3. Use of Improved Information Technology and Burden Reduction 3
4. Efforts to Identify Duplication and Use of Similar Information 4
5. Impact on Small Businesses or Other Small Entities 4
6. Consequences of Collecting the Information Less Frequently 4
7. Special Circumstances Relating to the Guidelines of 5 CFR 1320.5 4
8. Comments in Response to the Federal Register Notice and Efforts to Consult Outside the Agency 4
9. Explanation of Any Payment or Gift to Respondents 4
10. Assurance of Confidentiality Provided to Respondents 4
11. Justification for Sensitive Questions 4
12. Estimates of Annualized Burden Hours and Costs 4
13. Estimates of Other Total Annual Cost Burden to Respondents or Record Keepers 5
14. Annualized Cost to the Government 5
15. Explanation for Program Changes or Adjustments 5
16. Plans for Tabulation and Publication and Project Time Schedule 5
17. Reason(s) Display of OMB Expiration Date is Inappropriate 5
18. Exceptions to Certification for Paperwork Reduction Act Submissions 5
GenIC Package & Attachments
NOA
Supporting Statement A
ICR PRA Part II Worksheet
Att. 1: I-Cat Interview Protocol Guide and Questions
The Centers for Disease Control and
Prevention (CDC)’s Informatics Innovation Unit (IU) advances
the field of public health informatics through applied research and
innovation. IIU studies, prototypes, and tests new and innovative
technology-based tools and resources to maximize their effect on
public health. IIU’s resources are available to both CDC and
its partners in the public health community. However, many of IIUs
deliverables end up not being used or implemented despite the time
and effort spent developing the desired technology solution. IIU
wishes to understand if its CDC clients will undergo a design
sprint process to rapidly create usable technology solutions to
ensure they are needed.
Teams will use convenience sampling
methods to select subjects who are readily available and within
close proximity.
Populations and customers to be
interviewed include CDC staff, grantees, and the intended
technology end users in the general public.
Resulting data
will be used for internal CDC discussion and decision-making.
Project hopes to
understand if CDC clients and end users want and see value in
engaging in a design sprint to determine if the technology solution
is needed.
The Office of Technology and Innovation (OTI) in the Office of Associate Director for Science at the Centers for Diseases Control and Prevention, encourages, fosters, and develops innovative science, technologies, processes and policies that support the CDC/ATSDR. Federal scientific agencies, like the CDC, rely on research and scientific findings to help them develop solutions to public health problems which ultimately are disseminated to customers and stakeholders for adoption and use. However, anecdotal and empirical data show that many well-meaning, robust solutions are never used or adopted by the intended customer. This has resulted in a path littered with failed and unused government sponsored outputs. The CDC I-Catalyst program guides participants through a “customer discovery” process aimed at helping teams with a new solution to identify their customers. This is done by taking a team’s main assumptions about who their customer is, the exact problem they are solving for the customer, and how the customer wants to receive or use the solution from the team—and turning those assumptions into hypotheses which the teams will then test (mainly through interviews with potential customers). Only conversations with potential customers (stakeholders) can provide the facts from which hypotheses are proven or disproven about whether a solution (product, process, etc.) creates value for the intended beneficiaries. It is expected that participants will leave the program with the ability to evaluate and translate their insights into solutions that have high levels of efficacy and user acceptability. The information collection is necessary to guide CDC project teams to create usable solutions that are customer centric and meaningful to users, whether it’s adhering to recommendations, policies, protocol or interventions.
This request seeks approval for a GenIC approval for subproject I-Catalyst – IIU Design Sprint. IIU studies, prototypes, and tests new and innovative technology-based tools and resources to maximize their effect on public health. IIU’s resources are available to both CDC and its partners in the public health community. However, many of IIUs deliverables end up not being used or implemented despite the time and effort spent developing the desired technology solution. IIU wishes to understand if its CDC clients will go through a design sprint process to rapidly create usable technology solutions to ensure they are needed. The efforts of CDC activities is authorized under Section 301 of the Public Health Service Act 42 U.S.C.241.
The Centers for Disease Control and Prevention (CDC)’s Informatics Innovation Unit (IU) advances the field of public health informatics through applied research and innovation. IIU studies, prototypes, and tests new and innovative technology-based tools and resources to maximize their effect on public health. IIU’s resources are available to both CDC and its partners in the public health community. However, many of IIUs deliverables end up not being used or implemented despite the time and effort spent developing the desired technology solution. IIU wishes to understand if its CDC clients will participate in a design sprint process to increase the likelihood of building a useful and needed technology solution.
The project hopes to seek input from clients and end users on a design sprint process through I-Catalyst and determine how it can best be used to support the development of technology solutions. The information collected will be used for internal CDC decision making purposes and to provide suggestions for improving data hub services in support of development of public health solutions. The customer interviews will be conducted with CDC staff at CDC (epidemiologists, statisticians, health scientists) and external partners such as CDC grantees and technology end users in the general public. IIU works with CDC staff and programs to develop innovative public health technology solutions including: mobile applications, web applications, prototypes, wireframes, and low/high fidelity mock ups. Some of the technology solutions are developed for internal CDC users and others are developed for external users or audiences. As part of their work with CDC staff/programs, IIU asks the CDC client to identify the intended end users (internal or external). If the CDC program identifies an external audience or customer, IIU may ask for descriptions or examples of these users. For example, state and local public health department staff may be an external customer for which a CDC program is trying to improve their surveillance website or mobile application. If the technology solution is intended for an external customer, IIU will identify these respondents with the assistance of the CDC program.
The interviews will be conducted in person, on-site or by virtual video conferencing like Skype for Business or Adobe Connect (Att. 1 – Interview guide) with CDC staff, grantees, and technology end users in the general public. As part of their work with CDC staff/programs, IIU asks the CDC client to identify the intended end users (internal or external). If the CDC program identifies an external audience or customer, IIU may ask for descriptions or examples of these users. For example, state and local public health department staff may be an external customer for which a CDC program is trying to improve their surveillance website or mobile application. If the technology solution is intended for an external customer, IIU will identify these respondents with the assistance of the CDC program. Using formative interview protocols allows the interviewer to follow the respondent’s lead during in-person conversations. This wouldn’t be possible if a list of fixed questions were used. This also is not possible if automated, technological-based collection techniques, such as a web-based survey, are used. On-site, in-person interviews allow interviewers to establish rapport with respondents and produce visual cues for interpreting responses that may require further probing or clarification. However, there are instances where teams can use improved information technology such as Skype or video conferencing for interviews to reduce the burden and provide flexibility in responder’s schedule.
This is a unique I-Catalyst project and a new proposed solution. Other than proprietary business databases, there is no existing database that can provide the level of detail about the customer experiences, wants, and needs necessary for IIU to understand its clients and end users.
No small businesses will be involved in this project.
Data is collected once at this stage in the discovery process, respondents will participate in an interview once lasting no more than 30 minutes.
This request fully complies with the regulation 5 CFR 1320.5. There are no special circumstances.
Not Applicable
There is no exchange of payment or gifts to respondents for the voluntary interviews.
Activities for this request do not involve the collection of Individually Identifiable Information.
There are no sensitive data items to be asked of individual respondents. CDC Human Research Protection Office determined that data /IC is not research involving human subjects and IRB is not required - OADS Project Determination approval (Att. 5).
The project team will interview 250 respondents for this ICR. The project will interview CDC staff at CDC (epidemiologists, statisticians, health scientists) and external partners such as CDC grantees and technology end users in the general public. for an average of 30 minutes and maximum of 1 responses per respondent. Annualized burden will be 125 hours and an estimated annualized burden cost of $4,840.
Estimated Annualized Burden Hours
Table A: Estimated Annualized Burden Hours
Type of Respondents |
Form Name |
No. of Respondents |
No. of Responses per Respondent |
Avg. Burden per Response (in hrs.) |
Total Burden (in hrs.) |
CDC staff (epidemiologists, statisticians, Health Scientist), grantees, and technology end users |
Interview Guide |
250 |
1 |
30/60 |
125 |
Total |
|
125 |
Table B: Estimated Annualized Burden Costs
Type of Respondents |
Form Name |
No. of Respondents |
No. of Responses per Respondent |
Avg. Burden per Response (in hrs.) |
Total Burden (in hrs.) |
Hourly Wage Rate* |
Total Respondent Costs |
|
|
|
|||||
CDC staff (epidemiologists, statisticians, Health Scientist), grantees, and technology end users |
Interview Guide |
250 |
1 |
30/60 |
250 |
Average 38.72
|
$4840 |
|
|
|
|
|
|
|
$ 4840.00 |
*Average of hourly wage from http://www.bls.gov/home.htm
There are no projected cost burdens for reporting.
The project cost is associated with the CDC project team members responsible for conducting the interviews. These figures were estimated as the sum of the anticipated direct labor; fringe and burden on direct labor.
Project Staff Oversight |
Annual Cost |
CDC Cost: Health Scientist (5% of Time) |
$5,000.00 |
CDC Cost: PH Advisor (2% of Time) |
$3,600.00 |
Total |
$8,600.00 |
This information collection request is a new submission.
The proposed interviews will be conducted within 3-6 months after approval of GenIC. There is no planned publication from this information collection. Interim reports will be developed, which will incorporate data collected from these sources in 2017 and 2018.
The display of the OMB expiration date is not inappropriate.
There are no exceptions to the certification statement.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | I-Catalyst Program - IIU Design Sprint |
Subject | GenIC Submission under OMB #0920-1158 |
File Modified | 0000-00-00 |
File Created | 2021-01-22 |